JANSSEN DIAGNOSTICS LLC has a total of 74 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), Israel and Hong Kong. Its main competitors in its focus markets measurement, biotechnology and chemical engineering are IMG INST FUER MEDIZINISCHE GENOMFORSCHUNG PLANUNGSGESELLSCHAFT M B H, ZHENGZHOU ZHONGDAO BIOTECHNOLOGY CO LTD and PUSCAS IOAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 26 | |
#2 | Israel | 10 | |
#3 | Hong Kong | 7 | |
#4 | United States | 6 | |
#5 | Japan | 4 | |
#6 | Mexico | 4 | |
#7 | Brazil | 3 | |
#8 | Canada | 3 | |
#9 | China | 3 | |
#10 | WIPO (World Intellectual Property Organization) | 3 | |
#11 | Australia | 2 | |
#12 | Hungary | 2 | |
#13 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Chemical engineering | |
#4 | Computer technology | |
#5 | Pharmaceuticals | |
#6 | Environmental technology | |
#7 | Basic materials chemistry | |
#8 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Rao Galla Chandra | 18 |
#2 | Wang Yixin | 17 |
#3 | Connelly Mark Carle | 14 |
#4 | Foulk Brad | 9 |
#5 | Terstappen Leon W M M | 9 |
#6 | Smirnov Denis | 8 |
#7 | Palma John F | 7 |
#8 | Gross Steven | 7 |
#9 | Nielsen Karl | 6 |
#10 | Jatkoe Timothy | 6 |
Publication | Filing date | Title |
---|---|---|
WO2017152028A1 | Preservation of cellular components from cells with a preservative | |
AU2013221642A1 | Highly sensitive method for detecting low frequency mutations | |
EP2739138A1 | New methods for coupling of molecules to metal/metal oxide surfaces | |
MX2014000804A | Assay to capture and detect circulating multiple myeloma cells from blood. | |
IL206810D0 | Methods of identifying melanoma and kits for use therein | |
IL199798D0 | High sensitivity multiparameter method for rare event analysis in a biological sample | |
HUE031851T2 | Improved imaging of immunomagnetically enriched rare cells | |
EP2402758A2 | Methods and uses for identifying the origin of a carcinoma of unknown primary origin | |
EP1861509A2 | A method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells |